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1. SUMMARY 
A monoclonal lgG 1 antibody against F8 
fimbriae was obtained with the hybridoma tech-
nique using spieen cells from C3H/f rnice im-
munised with a fimbrial preparation of Escherichia 
coli 2980 (018ac: K5: H-: FIC, F8) and Sp 2/0 
Ag8 myeloma cells. The hybrid cells were cloned 
twice by lirniting dilution and grown in tissue 
culture. The monoclonal antibody was purified 
from culture supernatants on Protein A Sep-
harose. lt reacted with F8 fimbriae in colony blot, 
enzyme-linked immunosorbent assay (ELISA) and 
immunoblot after electrotransfer from sodium 
dodecyl sulphate-polyacrylarnide gel electrophore-
sis (SOS-PAGE) of fimbrial preparations. The 
antibody bound to and agglutinated F8-fimbria-
ted bacteria. 
• To whom correspondence should be addressed. 
2. INTRODUCTION 
Fimbriae are filamentaus protein structures ex-
tending from the bacterial surface, known to 
mediate the binding of bacteria to other cells 
[1-3). E. co/i fimbriae have been classified accord-
ing to their receptor requirements into those which 
bind mannose-containing receptars in a mannose-
sensitive (MS) way, and those which bind to other 
receptors in a mannose-resistant (MR) way [3]. 
MR fimbriae were found to be a functionally 
heterogenaus group. It is known that some 
fimbriae recognise galactose-cantaining receptors 
belanging ta the blood-group P system (P-
fimbriae) [4,5] and athers recognize parts of glyco-
phorin A on human erythrocytes (M-fimbriae) or 
sialic acid-containing receptors (S-fimbriae) (6,7]. 
The serological classification of fimbriae as F anti-
gens (F1-Fl3, Fy) [8,9) is independent of their 
receptor specificity. The Fl antigen correspands 
ta MS fimbriae and the ather F antigens are MR 
fimbriae, whereby P-fimbriae are associated with 
serotypes F7-F13. In this study we describe a 
manoclonal antibody against the E. co/i MR 
fimbrial antigen F8, belanging to the P-fimbriae 
[10). 
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3. MATERIALS AND METHODS 
3. 1. Bacteria and fimbriae 
The bacteria used are listed in Table 1. With 
the exception of 2131 and 21391, all strains were 
isolated from urine. Strain 2131 is a recombinant 
strain expressing F1A fimbriae on a genetic back-
gmund of E. coli K-12. Strain 21391 is an E. coli 
K-12 clone harbouring the recombinant plasmid 
pANN921, which codes for the F8-antigen. 
pANN921 was derived from a cosmid which was 
isolated from a E. coli K-12 gene bank of strain 
2980 (J. Hacker et al., manuscript in preparation). 
All strains were grown on Loeb agar at 37°C 
(strain 21391 in the presence of 20 JLS/rnl tetra-
cycline). The isolation of the fimbriae was done as 
described previously [11,12). Briefly, bacteria 
harvested from Loeb agar plates were suspended 
in 50 mM Tris buffer, pH 7.5, and treated with an 
Omnimixer (position 2; 3 x 3 min) at 4°C. The 
suspension was centrifuged at 10000 x g for 20 
Table 1 
E. coli strains used and their reactivity with the monoclonal 
, antibody 
The bacteria were grown on agar and, with the exception of 
strain 2131, did not express the F1A antigen. 
E. coli strains Reaction wi th 
Freiburg Seroformula the monoclonal 
collection antibody in 
number colony blot 
and ELISA 
2980 a 018ac: KS: H-: F1C, F8 + 
21472 018ac:KS:H- :F1C, F8 + 
21473 018ac: KS : H- : Fl C, F8 + 
21474 018ac: K5: H-: FlC, F8 + 
21475 018ac: K5: H- : F1C, F8 + 
20043 083 : KS : H- : F1 C, Fy 
21084 06: K2: Hl: FlC. F7 
21085 015 : K- : H5 : F8 + 
21478 075:K+ :H5:F8 + 
21479 075: K + : HS: F8 + 
21480 075 : K + : H5: FS + 
21086 02: K5: H4: F9 
21087 07:K1:Hl:Fl0 
21088 01: Kl: H7: Fll 
21089 016:K1:H- :F12 
2131 K-12: F1A (recombinant) 
21391 K-12: F8 (cloned) + 
" Fimbriae of this strain were used as immunogen. 
min and the supernatant was recentrifuged at 
30000 X g for 20 min. After centrifugation of the 
second supernatant at 100 000 X g for 2 h, the 
fimbriae were obtained as a pellet. They were 
resuspended in 50 mM Tris buffer. pH 7.5. 
3.2. Monoclonal anribodies 
Fernale C3H/f mice, 6-8 weeks old, were 
injected subcutaneously and intraperitoneally with 
the fimbrial preparation from E. coli 2980 (20 f.Lg 
protein in Freund's complete adjuvant) twice in a 
4-week interval. Three weeks after the second 
injection the mice were given 20 JLg protein in PBS 
intravenously, and 3 days later they were killed 
with ether. Spleen cells (10 8) of the immunised 
mice were fused with Sp2/0-Ag8 myeloma cells 
(107 ) [13] using polyethylene glycol1540 as fusing 
agent. Hybrid clones were screened for homolo-
gous anti-F, anti-0 and K specificity by the ELISA 
technique, and positive clones were subcloned by 
limiting dilution. 
Supernalants of the clones were purified by 
affinity chromatography on protein A-Sepharose 
48 (Pharmacia, Uppsala, Sweden) at pH 8.6, and 
after washing the column with 50 mM Tris-HCI 
150 mM NaCl pH 8.6, elution was done with 50 
mM glycin-HCI/150 mM NaCI at pH 2.3. Anti-
body-containing fractions were adjusted to pH 7.5 
and dialysed against PBS. The purified antiborlies 
were stored at - 80°C at a concentration of 2.5 
mgjml. 
3. 3. Serological techniques 
For ELISA tests [14] microtitre plates were 
coated at 37°C with antigen diluted in 50 mM 
carbonate buffer, pH 9.6. The antigen concentra· 
tion was 20 J.~g/ml with protein and 100 J.~g/ml 
with LPS or capsular (K) polysaccharide. When 
fimbriated bacteria were used as antigens, 108 cells 
per ml were used after fixation with gluraralde-
hyde [15). The unspecific sites were blocked with 
4% (w jv) BSA in PBS/0.05% (v jv) Tween-20. pH 
1.5. Peroxidase-conjugated goat anti-mouse im-
munoglobulin (Medac, Hamburg) was used and 
the peroxidase substrate was 2,2' -azino(3-ethyl-
benzenthiazoline sulphonic acid) in phosphate 
buffer at pH 6. The extinction was measured at 
405 nm. 
For immunoblots [16] fimbrial subunits were 
electrotransferred (90 mA, 16 h, 4°C) from SDS-
polyacrylamide gels to nitrocellulose sheets in 25 
mM Tris/190 mM glycin, pH 7.5, containing 20% 
methanol. The nitrocellulose was washed with 
phosphate-buffered saline (PBS), incubated with 
4% bovine serum albumin (BSA) in PBS/0.05% 
Tween-20 for 1 h, washed again and incubated 
with the purified monoclonal antibody in a con-
centration of about 10 }'g/ml in PBS-Tween over-
night at 4°C. After washing at least 4 times with 
0.05% Tween-20 in PBS, the sheets were incubated 
for 1 h at room temperature with peroxidase-con-
jugated goat anti-mouse IgG (Miles). After several 
washings they were incubated for 1 h at room 
temperature with substrate/H 20 2 and then 
washed with water. Reaction of protein bands 
with the antiborlies was indicated by a dark blue-
grey colour. The reagent was 4-chloro-1-naphthol 
(30 mg in 10 ml methanol, to which were added 50 
ml of 10 mM Tris-HCI, pH 7.5, containing 200 
mM NaCI and 20 ~-tl H 20 2 ). 
For colony blots, single colonies were blotted 
from Loeb agar plates to nitrocellulose paper 
sheets, air dried, and washed with PBS-Tween/4% 
BSA containing 0.02% NaN3. The procedure was 
continued as described for the immunoblot. 
Agglutinations were performed with bacterial 
suspensions in 0.9% NaCI (A 600 = 1). The antibod-
ies were also diluted in 0.9% NaCI. After incuba-
tion (1 h at 37°C and then 16 h at 4°C), agglutina-
tionwas estimated microscopically. 
3.4. SDS-PAGE 
The disintegration of fimbriae and their electro-
phoretic separation on polyacrylamide gels (run-
ning gel 13%, separating gel 5%) has beeil de-
scribed [12,16]. 
3.5. Radioiodination of antibodies 
The purified antibodies were iodinated with the 
chloramine-T method [17]. Free iodine was re-
moved by chromatography on Sephadex G-25 with 
PBS as eluent. 
3.6. Absorption of 11Jl-antibody to fimbriated E. 
coli 
E. co/i bacteria, grown on agar at 37°C for 40 
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h, were suspended in PBS to a density of 109 
cellsjml. Of each suspension, 1 ml was centri-
fuged at 8000 X g for 15 min and the respective 
pellets were gently resuspended in PBS containing 
5 p.g of the monoclonal anti-F8 antibody. After 
shak.ing gently for 60 min at 37°C, the mixtures 
were centrifuged and washed 5 times with PBS, by 
centrifuging as above. The final pellet was sus-
pended in 1 ml PBS and 50-~&1 portions were 
counted in a y-counter. 
4. RESULTS 
4. I. Bacteria and fimbriae 
E. co/i 2980 (018ac: K5: H-) used for the pro-
duction of monoclonal anti-fimbrial antibodies, 
expresses two types of fimbriae, defined as F1 C 
and F8, by crossed immunoelectrophoresis [9,10]. 
For comparison, F test strains and strains in which 
the F8 antigen had been detected by crossed im-
mune electrophoresis. as weil as the E. coli K-12 
strain expressing the cloned F8-antigen (Hacker, 
manuscript in preparation) were included. The 
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Fig. 1. (A) SOS-PAGE of fimbrial preparations from E. co/i 
2980 (F8, F1C), 21085 (F8) and 20043 (FlC, Fy) (from Jeft to 
right). Of each preparation 15 1'8 protein were applied; the gel 
was stained with Coomassic blue. (8) lmmunoblot of the same 
fimbrial preparations as in 1A. after electro-transfer to nitro-
cellulose. The immunostaining is described in the text. The 
monoclonal antibody was used in a concentration of about 10 
1'8/ml and the conjugate or anti-antibody and peroxidasewas 
used in a dilution of 1:1000. 
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Fig. 2. (A) SOS-PAGE of fimbrial preparations from E. coli 
strains expressing fimhrial F8 antigen alone or in combination 
with the fimbrial FIC antigen. The preparations are (from left 
to right) from strains 2980. 21472-21475 ( E. co/i 
018ac: K5: H- : F8, Fy). 21478-21480 ( E. ,·oli 
015: K + : HS: F8), 21085 ( E. co/i 015: K- : HS: F8), 21391 
( E. coli K-12: F8, cloned; Hacker, in preparation). From each 
preparation, 15 1!8 protein was applied; the gel was stained 
with Coomassie blue. (8) Immunoblot of the same fimbrial 
preparations, after electro-transfer to nitrocellulose. The mono-
clonal antibody was used in a concentration of ahout 10 
1'8/ml and the conjugate of anti-antibody and peroxidase was 
used at a dilution of 1 : 1000. 
fimbriae were sheared from the bacteria and puri-
fied by sequential centrifugation. 
4. 2. Production and characterisation of monoclonal 
antibodies 
Fernale CJH/f mice, 6-8 weeks old, were im-
munised with isolated fimbriae of E. co/i 2980 and 
their spieen cells were fused with Sp2/0-Ag8 
myeloma cells [13]. The supernatants of the hybrid 
clones were screened by ELISA for antibody 
Tablc 2 
Adsorption of 125 1-labelled monoclonal anti-F8 antibody to E . 
coli cells 
5 J!g Antibody protein (9.5 X 10 6 cpm) was added to tOq E. coli 
cells in a total volume of 1 ml. 
Bacterial 
strain 
2980 
21085 8 
20043 
Fimbrial 
antigens 
expressed 
FIC,F8 
F8 
F1C,Fy 
Monoclonal anti-F8 
antibody adsorbed 
cpm ( x 105 ) p.g protein 
adsorbed 
. 9.38 
0.98 
0.06 
0.5 
0.05 
0.017 
a Electron microscopy revealed that strain 21085 was less 
fimbriated than strain 2980. 
specificity with isolated fimbriae, LPS and capsu-
lar polysaccharide of the immunizing strain. One 
clone exhibiting only anti-fimbrial specificity was 
subcloned twice by limiting dilution and propa-
gated in tissue culture. The supernatant which 
showed anti-fimbrial activity was purified by af-
finity chromatography on protein-A Sepharose 48. 
Agar gel double diffusion test with anti-mouse lg 
antisera showed that the monoclonal antibody was 
IgGl, "· 
4.3. Anti-fimbria/ specific:ity 
The antibody was analysed by ELISA and col-
ony blot for cross-reactions with fimbriae of E. 
coli strains expressing F8, Fl C or other E. coli F 
antigens including those of F7-F12 test strains. It 
reacted only with strain 2980 and F8 test strain 
21805. and not with strains which do not express 
the F8 antigen. To ensure F8 specificity, the anti-
body was used in colony blots and ELISA with E. 
co/i strains expressing the F8 antigen, including 
the E. coli K-12 strain carrying the recombinant 
DNA for F8-fimbriae (Hacker et al.. manuscript 
in preparation). All these strains reacted in both 
assays. ELISA titre being in the range of 
10- 5-10- 6 (Table 1). 
Fig. 1A shows that the fimbrial preparation of 
E. coli 2980 exhibited two major peptide bands in 
SOS-PAGE (16.6 and 19.7 kDa). Previous im-
munoblot analysis (21) had shown that the smaller 
peptide (16.6-kDa) corresponded to the fimbrial 
FlC subunit. Immunoblot with the monoclonal 
antibody revealed reactivity with the slower-mov-
ing 19.7-kDa band (Fig. lB). Fimbrial prepara-
tions of all strains exhibiting the F8 antigen were 
analyzed in immunoblots with the monoclonal 
antibody. As shown in Fig. 2, they expressed in 
SDS-PAGE either only one (19.7-kDa) band or 
two (16.6-kDa and 19.7-kDa) bands, and only the 
19.7-kDa band was reactive with the antibody. 
4. 4. Reaction of the monoclonal anti-F8 antibody 
with whole E. coli cells 
The monoclonal antibody (2.5 mgjml) ag-
glutinated strain 2980 to a dilution of 1: 4000 (in 
saline). Binding of the antibody to the bacteria 
was also monitored with E. coli 2980 and with F8 
test strain 21085 using 1251-Iabelled antibody. As 
shown in Table 2, strain 2980 bound 10 times 
more antibody protein (per 109 cells) than test 
strain 21085. Electron microscopic inspection (not 
shown) revealed that strain 21085 was less fimbri-
ated than strain 2980. Binding of the monoclonal 
antibody to strain 20043, which was fimbriated 
but did not express F8 fimbriae, was 3 log num-
bers lower, the values corresponding practical1y to 
blank values. 
5. DISCUSSION 
In the course of our immunochemical studies of 
E. coli surface antigens we prepared a monoclonal 
antibody against the fimbriae of uropathogenic E. 
co/i 2980 (018ac: K5), which had been described 
previously [12). Crossed immunoelectrophoresis 
had previously shown that this strain expresses the 
fimbrial F1 C and F8 antigens. The monoclonal 
antibody, obtained by hybridisation [13] of spieen 
cells from C3H/f mice immunised with the 
fimbrial preparation with non-producer Sp2/0-
Ag8 hybridoma cells, reacted with the homologous 
fimbrial preparation but not with the 018ac-LPS 
or the K5-polysaccharide. lt was therefore taken 
to be fimbriae-specific. Only E. coli strains con-
taining the F8 antigen reacted with the mono-
clonal antibody in colony blot and ELISA. The F8 
antigen is associated mainly with 2 0: K: H com-
binations (018ac: K5: H-and 075: K: H5) prob-
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ably reflecting two clones ([9], I. ßrskov, unpub-
lished observation). Several such strains were 
therefore analysed by immunoblotting. Fimbrial 
preparations from strains 2980 and 21472-21475 
( E. coli 018ac: K5: H-) exhibited two bands, 
19.7 and 16.6 kDa, in SOS-PAGE. The mono-
clonal antibody reacted only with the 19.7-kDa 
band, which emphasised that this band represents 
the fimbrial F8 subunit. The 16.6-kDa band has 
previous been identified as fimbrial F1C subunit 
[21). Strains 21478-21480 ( E. coli 015: K + : H5) 
and K mutant 21085 exhibited only the 19.7-kDa 
band, which reacted with the monoclonal anti-
body. The genetic determinant coding for F8-
fimbriae was recently cloned from the chro-
mosome of the 018: K5 strain 2980 (Hacker et al., 
manuscript in preparation). Fimbriae from this E. 
co/i K-12 clone carrying the recombinant F8-DNA 
(21391) also reacted with the monoclonal anti-
body. 
Reactivity of the monoclonal antibody in 
ELISA as well as in and colony blot and im-
munoblot indicated that the F8-specific antibody 
recognises a surface-expressed sequential rather 
than a conformational epitope. This was also 
shown by absorbing 125 1-labelled antibody to 
whole fimbriated E. co/i 2980 and F8 test strain 
21085. In this test E. co/i 2980 reacted 10-fold 
better than 21085, which was probably due to a 
lesser fimbriation of the latter, as shown by elec-
tron microscopy. Surface accessibility of the F8 
antigen to the monoclonal antibody was also dem-
onstrated by the agglutination of E. coli 2980, 
although this was observed only after 24 h. 
The results described here allow a complete 
fimbrial characterization of uropathogenic E. co/i 
2980. Together with other results on monoclonal 
anti-fimbrial antiborlies [18-20]. they expand the 
spectrum of fimbriae-specific probes for E. co/i 
pathogens. 
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